JP2011509650A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011509650A5 JP2011509650A5 JP2010526077A JP2010526077A JP2011509650A5 JP 2011509650 A5 JP2011509650 A5 JP 2011509650A5 JP 2010526077 A JP2010526077 A JP 2010526077A JP 2010526077 A JP2010526077 A JP 2010526077A JP 2011509650 A5 JP2011509650 A5 JP 2011509650A5
- Authority
- JP
- Japan
- Prior art keywords
- ferm
- item
- antibody
- antigen
- binding fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000427 antigen Substances 0.000 claims 1
- 102000036639 antigens Human genes 0.000 claims 1
- 108091007433 antigens Proteins 0.000 claims 1
- 239000012634 fragment Substances 0.000 claims 1
- 210000004408 hybridoma Anatomy 0.000 claims 1
- 229940126619 mouse monoclonal antibody Drugs 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2052708P | 2008-01-11 | 2008-01-11 | |
| PCT/JP2009/050606 WO2009088105A1 (en) | 2008-01-11 | 2009-01-13 | HUMANIZED ANTI-α9 INTEGRIN ANTIBODIES AND THE USES THEREOF |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011509650A JP2011509650A (ja) | 2011-03-31 |
| JP2011509650A5 true JP2011509650A5 (cg-RX-API-DMAC7.html) | 2012-02-09 |
Family
ID=40853211
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010526077A Pending JP2011509650A (ja) | 2008-01-11 | 2009-01-13 | ヒト化抗−α９インテグリン抗体及びその使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US8821863B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP2245156A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2011509650A (cg-RX-API-DMAC7.html) |
| KR (1) | KR101597842B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN101918555B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2009203350B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2711771C (cg-RX-API-DMAC7.html) |
| WO (1) | WO2009088105A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8221754B2 (en) * | 2006-07-12 | 2012-07-17 | Gene Techno Science Co., Ltd. | Antihuman α9 integrin antibody and use of the same |
| AU2010221993C1 (en) * | 2009-03-10 | 2015-07-09 | Gene Techno Science Co., Ltd. | Generation, expression and characterization of the humanized K33N monoclonal antibody |
| WO2011004847A1 (ja) * | 2009-07-07 | 2011-01-13 | 一般財団法人化学及血清療法研究所 | 新規ヒト化抗ヒトα９インテグリン抗体 |
| CN116376983A (zh) | 2012-07-27 | 2023-07-04 | 希望之城 | 一种递送ul128复合体和预防cmv感染的mva疫苗 |
| US20150322152A1 (en) * | 2012-11-30 | 2015-11-12 | Institut Pasteur | Use of anti-fcyri and/or anti-fcyriia antibodies for treating arthritis, inflammation, thrombocytopenia and allergic shock |
| TWI700300B (zh) * | 2014-09-26 | 2020-08-01 | 日商中外製藥股份有限公司 | 中和具有第ｖｉｉｉ凝血因子（ｆｖｉｉｉ）機能替代活性的物質之抗體 |
| US10946095B2 (en) | 2015-09-02 | 2021-03-16 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Antibodies specific to human T-cell immunoglobulin and ITIM domain (TIGIT) |
| EP3347045A4 (en) | 2015-09-10 | 2019-08-28 | City of Hope | MVA-GH / GL-PC VACCINATED ANTIBODIES FOR NEUTRALIZING THE INFECTIOSITY OF HUMAN CYTOMEGALOVIRUS AND METHOD THEREFOR |
| EP3802615A4 (en) | 2018-06-04 | 2022-04-13 | Precigen, Inc. | Muc16 specific chimeric antigen receptors and uses thereof |
| CN117285619B (zh) * | 2023-09-28 | 2025-11-25 | 广西壮族自治区兽医研究所 | 一种鸡细小病毒的单克隆抗体及其应用 |
Family Cites Families (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8308235D0 (en) | 1983-03-25 | 1983-05-05 | Celltech Ltd | Polypeptides |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US5807715A (en) | 1984-08-27 | 1998-09-15 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin |
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| AU600575B2 (en) | 1987-03-18 | 1990-08-16 | Sb2, Inc. | Altered antibodies |
| US5258498A (en) | 1987-05-21 | 1993-11-02 | Creative Biomolecules, Inc. | Polypeptide linkers for production of biosynthetic proteins |
| JP3095168B2 (ja) | 1988-02-05 | 2000-10-03 | エル． モリソン，シェリー | ドメイン‐変性不変部を有する抗体 |
| US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| DE68927933T2 (de) | 1988-09-02 | 1997-08-14 | Dyax Corp | Herstellung und auswahl von rekombinantproteinen mit verschiedenen bindestellen |
| IL162181A (en) * | 1988-12-28 | 2006-04-10 | Pdl Biopharma Inc | A method of producing humanized immunoglubulin, and polynucleotides encoding the same |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| GB8928874D0 (en) | 1989-12-21 | 1990-02-28 | Celltech Ltd | Humanised antibodies |
| US5859205A (en) * | 1989-12-21 | 1999-01-12 | Celltech Limited | Humanised antibodies |
| US5780225A (en) | 1990-01-12 | 1998-07-14 | Stratagene | Method for generating libaries of antibody genes comprising amplification of diverse antibody DNAs and methods for using these libraries for the production of diverse antigen combining molecules |
| WO1991010737A1 (en) | 1990-01-11 | 1991-07-25 | Molecular Affinities Corporation | Production of antibodies using gene libraries |
| US5314995A (en) | 1990-01-22 | 1994-05-24 | Oncogen | Therapeutic interleukin-2-antibody based fusion proteins |
| US5427908A (en) | 1990-05-01 | 1995-06-27 | Affymax Technologies N.V. | Recombinant library screening methods |
| GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
| WO1992003918A1 (en) | 1990-08-29 | 1992-03-19 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| US5698426A (en) | 1990-09-28 | 1997-12-16 | Ixsys, Incorporated | Surface expression libraries of heteromeric receptors |
| DK0564531T3 (da) | 1990-12-03 | 1998-09-28 | Genentech Inc | Berigelsesfremgangsmåde for variantproteiner med ændrede bindingsegenskaber |
| DK1471142T3 (da) | 1991-04-10 | 2009-03-09 | Scripps Research Inst | Heterodimere receptor-biblioteker under anvendelse af fagemider |
| DE69233482T2 (de) | 1991-05-17 | 2006-01-12 | Merck & Co., Inc. | Verfahren zur Verminderung der Immunogenität der variablen Antikörperdomänen |
| CA2110799A1 (en) | 1991-06-14 | 1992-12-23 | Arnold H. Horwitz | Microbially-produced antibody fragments and their conjugates |
| US5565332A (en) | 1991-09-23 | 1996-10-15 | Medical Research Council | Production of chimeric antibodies - a combinatorial approach |
| DE69233745D1 (de) | 1991-12-02 | 2008-10-23 | Cambridge Antibody Tech | Herstellung von Autoantikörpern auf Phagenoberflächen ausgehend von Antikörpersegmentbibliotheken |
| US5733743A (en) | 1992-03-24 | 1998-03-31 | Cambridge Antibody Technology Limited | Methods for producing members of specific binding pairs |
| ZA932522B (en) | 1992-04-10 | 1993-12-20 | Res Dev Foundation | Immunotoxins directed against c-erbB-2(HER/neu) related surface antigens |
| JPH08501085A (ja) | 1992-08-26 | 1996-02-06 | プレジデント アンド フェローズ オブ ハーバード カレッジ | 抗腫瘍剤としてのサイトカインｉｐ−１０の利用 |
| US5639641A (en) | 1992-09-09 | 1997-06-17 | Immunogen Inc. | Resurfacing of rodent antibodies |
| CA2163345A1 (en) | 1993-06-16 | 1994-12-22 | Susan Adrienne Morgan | Antibodies |
| JPH09506262A (ja) | 1993-12-08 | 1997-06-24 | ジェンザイム・コーポレイション | 特異的抗体の製造方法 |
| DE69534347T2 (de) | 1994-01-31 | 2006-05-24 | Trustees Of Boston University, Boston | Bibliotheken aus Polyklonalen Antikörpern |
| US5516637A (en) | 1994-06-10 | 1996-05-14 | Dade International Inc. | Method involving display of protein binding pairs on the surface of bacterial pili and bacteriophage |
| JP2978435B2 (ja) | 1996-01-24 | 1999-11-15 | チッソ株式会社 | アクリロキシプロピルシランの製造方法 |
| AU2002244968B2 (en) | 2001-04-05 | 2007-07-26 | Astellas Pharma Inc. | Anti-osteopontin antibody and use thereof |
| US7456260B2 (en) * | 2002-06-17 | 2008-11-25 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Humanized antibody |
| ITRM20030601A1 (it) * | 2003-12-24 | 2005-06-25 | Lay Line Genomics Spa | Metodo per l'umanizzazione di anticorpi e anticorpi umanizzati con esso ottenuti. |
| CA2576093A1 (en) * | 2004-08-03 | 2006-02-09 | Mochida Pharmaceutical Co., Ltd. | Pharmaceutical compostion containing meltrin antagonist |
| IN266863B (cg-RX-API-DMAC7.html) * | 2005-01-13 | 2015-06-10 | Gene Techno Science Co Ltd | |
| US8221754B2 (en) | 2006-07-12 | 2012-07-17 | Gene Techno Science Co., Ltd. | Antihuman α9 integrin antibody and use of the same |
-
2009
- 2009-01-13 EP EP09700470A patent/EP2245156A4/en not_active Withdrawn
- 2009-01-13 CN CN2009801020264A patent/CN101918555B/zh not_active Expired - Fee Related
- 2009-01-13 EP EP11174722.6A patent/EP2388323B1/en not_active Not-in-force
- 2009-01-13 JP JP2010526077A patent/JP2011509650A/ja active Pending
- 2009-01-13 WO PCT/JP2009/050606 patent/WO2009088105A1/en not_active Ceased
- 2009-01-13 KR KR1020107015294A patent/KR101597842B1/ko not_active Expired - Fee Related
- 2009-01-13 CA CA2711771A patent/CA2711771C/en not_active Expired - Fee Related
- 2009-01-13 AU AU2009203350A patent/AU2009203350B2/en not_active Ceased
- 2009-01-13 US US12/812,455 patent/US8821863B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011509650A5 (cg-RX-API-DMAC7.html) | ||
| JP2013198490A5 (cg-RX-API-DMAC7.html) | ||
| JP2015028021A5 (cg-RX-API-DMAC7.html) | ||
| WO2013037484A3 (en) | Anti-aplhabetatcr antibody | |
| ZA201004752B (en) | Humanized anti-human nkg2a monoclonal antibody | |
| WO2009120927A3 (en) | Methods of treatment | |
| NZ604643A (en) | S100a4 antibodies and therapeutic uses thereof | |
| IL197928A (en) | A monoclonal antibody munched on steap-1, its immunoconjugates its uses | |
| NZ602294A (en) | Monoclonal antibodies against c-met | |
| IL202232A (en) | A method of making a human antibody derived from a rabbit parent antibody that binds to a desired antigen as well as a human antibody or fragment thereof produced by this method | |
| NZ616382A (en) | Antibodies specific to cadherin-17 | |
| HRP20140266T1 (hr) | Postupci inhibiranja vezanja endosijalina na ligande | |
| RU2017128882A (ru) | Антитела к биотину и способы их применения | |
| WO2008043145A8 (en) | Hybridomas producing antibodies against non functional p2x7 receptor | |
| ZA200905447B (en) | Multivariable antigens complexed with targeting humanized monoclonal antibody | |
| NZ597023A (en) | Monoclonal antibodies that bind to hGM-CSF and medical compositions comprising same | |
| JP2016520514A5 (cg-RX-API-DMAC7.html) | ||
| NZ592214A (en) | Improved Interleukin-6 receptor antibody molecule | |
| MY157532A (en) | A monoclonal antibody to cd44 for use in the treatment of head and neck squamous cell carcinoma | |
| JP2010513228A5 (cg-RX-API-DMAC7.html) | ||
| SG178886A1 (en) | Humanized anti-cdcp1 antibodies | |
| JP2010509937A5 (cg-RX-API-DMAC7.html) | ||
| NZ595863A (en) | Antibodies to egfl7 and methods for their use | |
| JP2011237442A5 (cg-RX-API-DMAC7.html) | ||
| NZ631473A (en) | Anti-cd52 antibodies |